Stockreport

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF Believes Transaction Significantly Undervalues QuanterixHighlights that Quanterix’s Board is Essentially Rescuing Akoya at the Direct Expense of Quanterix ShareholdersTr [Read more]